一项正在进行的关于抗喘药物查动物模型的审查
Shivam Singh1, Sunita Kularia1, Shivakshi Shukla1
1Department of Pharmacology, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, Rajasthan, India.
Frontiers in pharmacology
|February 21, 2025
概括
目前的喘动物模型有局限性. 本次审查强调了需要更具预测性的模型,以改善抗喘药物开发,减少人体试验中的失败.
科学领域:
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
- 药物开发 药物开发
背景情况:
- 喘在全球影响3亿人,50年来新药开发有限.
- 现有的动物模型往往无法预测人类的疗效和安全性,需要更好的模型.
- 对于创新的抗喘疗法有着显著的未满足的需求.
研究的目的:
- 审查抗喘药物的机制和疗效.
- 分析当前遗传和常规喘动物模型的优缺点.
- 强调在抗喘药物发现中需要改进预测模型的需要.
主要方法:
- 在喘研究中使用的体外和体外动物模型的全面审查.
- 总结了各种模型的特征和意义,包括组胺受体测定,细胞培养和分离器官制剂.
- 包括体内模型,如试验猪和小鼠研究,评估支气管,呼吸道反应和炎症.
主要成果:
- 为了研究喘,存在各种体外和体内动物模型.
- 这些模型提供了对药物机制和疗效的见解,但在预测人类反应方面存在局限性.
- 该评论详细介绍了这些模型中使用的特定测定和实验设置.
结论:
- 目前用于喘研究的动物模型有好处,但也有显著的局限性.
- 迫切需要更复杂和更具预测性的动物模型.
- 改善临床前模型对于减少翻译失败和推进抗喘药物开发至关重要.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...


